RxDoctor Payments Data

Krista Shackelford, MD

Dermatology · Wichita, KSNPI 1922038801

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 29.4% of the total. Reporting peaked in 2024 at $708 and has fallen 61.9% since, to $270 in 2025. That places this record below the midpoint for dermatology clinicians in KS, where the typical reported total is $1,741.

$2,164in general payments, 2019–2025

Across 97 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$636
  • E.r. Squibb & Sons, L.L.C.$490
  • Novartis$465
  • Johnson & Johnson$95
  • LEO Pharma Inc.$87
  • Dermavant Sciences, Inc.$65
  • plus $326 from 9 others

What the payments were for

  • Food & beverage$2,06195%
  • Education$1045%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,164 in reported general payments places this provider in the 50th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$206,951
Medicare patients
917
Services billed
2,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast15$64,341
Fluorouracil73$5,881
Clobetasol Propionate98$4,569
Ketoconazole96$1,388
Tretinoin17$1,335
Doxycycline Hyclate45$1,169
Metronidazole27$1,155
Fluocinolone AcetonideFluocinolone/Shower Cap16$1,098
Tacrolimus11$1,058
Imiquimod30$893
Triamcinolone Acetonide108$875
Clindamycin Phosphate17$618
Gentamicin Sulfate16$573
Fluocinonide18$530
Spironolactone26$427

Paid to pharmacies, not to this prescriber.

Other dermatology in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →